FRCA Notes


Aspiring


  • Aspirin (acetylsalicylic acid) is an aromatic ester of acetic acid
Aspirin chemical structure
  • Primary and secondary prevention in stroke/myocardial infarction
    • Reduces the risk of unstable angina progressing to MI
    • Reduces mortality following MI
    • Reduces risk of stroke in those who've had a TIA
  • Analgesic/anti-inflammatory

  • At low dose (75mg/day):
    • Irreversibly, selectively inhibits platelet COX via enzyme acetylation
    • Preserves vessel wall COX
  • This reduces production of TXA2 and therefore reduces thromboxane-induced platelet aggregation and vasoconstriction
  • Vessel-wall prostacyclin synthesis is unaltered and therefore vasodilation occurs

Absorption

  • Weak acid with a pKa of 3
    • Therefore essentially wholly unionised in the stomach, facilitating absorption
    • However more drug is overall absorbed in the ileum/small bowel due to its increased surface area
    • Acetylsalicylate and salicylate ions may be trapped in the alkaline environment of the mucosal cells
      • Unable to reach systemic circulation, therefore increased propensity to cause local effects

  • 65-70% oral bioavailability

Distribution

  • 85% protein bound (mostly to albumin as a weak acid)

Metabolism

  • Rapidly hydrolysed by intestinal and hepatic esterases to salicylate and acetic acid
  • Further hepatic metabolism:
    • Glycine conjugation to salicyluric acid
    • Glucuronide derivatives

  • Elimination half life is short (15-30mins) if obeying 1st order kinetics
  • Significantly prolonged if glycine conjugation becomes saturated (as in overdose) → zero order kinetics

Excretion

  • Salicylate and metabolites are excreted in the urine
  • Excretion is enhanced under alkaline conditions

Metabolic effects

  • Effect on the metabolic state are of little significance, except in aspirin overdose i.e. salicylate poisoning
  • Uncouples oxidative phosphorylation
    • This increases oxygen consumption and carbon dioxide production
    • Initially minute ventilation increases to keep PaCO2 static
    • When aspirin levels increase there is direct stimulation of the respiratory centre to cause respiratory alkalosis
    • Picture complicated by concurrent metabolic acidosis
    • (NB in children, rising aspirin levels depress the respiratory centre, causing mixed respiratory/metabolic acidosis)

Reye's syndrome

  • An uncommon syndrome that mainly occurs in children
  • Leads to:
    • Widespread mitochondrial damage
    • Fatty change in the liver and hepatic failure
    • Encephalopathy and cerebral oedema
  • Overall mortality 40%
  • Aspirin should be avoided in those <16yrs old (except in specific indications e.g. JIA)